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Adipose tissueIncreased triglyceride accumulation in adipocytes caused by a misbalance between energy intake and energy
consumption, results in increased adipocyte size, excess adipose tissue, increased body weight and ultimately,
obesity. It iswell established that enlarged adipocytes exhibitmalfunctions that contribute towhole body insulin
resistance, a key factor for the development of type 2 diabetes. However, the underlyingmolecular cause for dys-
functional adipocyte behavior and signaling is poorly understood. Since the adipocyte cell surface proteome, or
surfaceome, represents the cellular signaling gateway to the microenvironment, we studied the contribution of
this subproteome to adipocytemalfunctions in obesity. By using the chemoproteomic Cell Surface Capture (CSC)
technology, we established surfaceome maps of primary adipocytes derived from different mouse models for
metabolic disorders. Relative quantitative comparison between these surfaceomemaps revealed a set of cell sur-
face glycoproteinswithmodulated location-speciﬁc abundance levels. RNAimediated targeting of a subset of the
detected obesity modulated cell surface glycoproteins in an in vitromodel system provided functional evidence
for their role in adiponectin secretion and the lipolytic activity of adipocytes. Thus, we conclude that the identi-
ﬁed cell surface glycoproteins which exhibit obesity induced abundance changes and impact adipocyte function
at the same time contribute to adipocytemalfunction in obesity. The regulation of their concerted activities could
improve adipocyte function in obesity.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
Obesity is a major risk factor for secondary disorders including type
2 diabetes, atherosclerosis, hypertension and other malignancies and is
becoming a paramount problem in industrialized countries. In 2007, 1.1
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B.V. Open access under CC BY license.million of them to be obese [1]. Key factors for developing type 2 diabe-
tes are weight gain, physical inactivity and a variety of genetic factors
[2,3]. Obesity is characterized by increased adipose tissue depot sizes,
which can result from an increased differentiation of pre-adipocytes
into mature adipocyte (hyperplasia), or from an increased average cell
size of existing adipocytes (hypertrophy). In particular the hypertrophic
phenotype of adipocytes has been associated with obesity-dependent
disorders [4,5]. Adipose tissue is the major organ for storing excess en-
ergy in the form of triglycerides. Besides its role in energy storage adi-
pose tissue also has several important endocrine functions. In obesity,
mature adipocyte dysfunctions such as insulin resistance or reduced
adiponectin secretion, contribute to the development of type 2 diabetes.
Insulin resistance of the adipose tissue is associated with reduced glu-
cose uptake into adipocytes. Furthermore, basal lipolysis of adipocytes
is typically increased during obesity leading to increased circulating
free fatty acid levels in the fasted state and ectopic fat deposition. This
is exuberated by the fact that, adipose tissue in obese patients also
shows a blunted response to catecholamines [6,7]. In addition to meta-
bolic de-regulation, the adipokine proﬁle changes during obesity, lead-
ing to elevated levels of tumor necrosis factor-alpha, interleukin 6 and
resistin, whereas adiponectin levels are decreased, which further pro-
motes insulin resistance in peripheral tissues [8].
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ganism and adipocytes relies at least in part on information process-
ing mediated by cell surface proteins, which also represent proxies
for intracellular network changes. The qualitative composition of
the surfaceome, as well as the quantity and activity of cell surface
proteins are enabling but also limiting speciﬁc information exchange
between adipocytes and extracellular signaling partners. Due to this
important function in information processing, cell surface proteins
are also sought after as drug targets. Approximately 60% of drug tar-
gets are membrane proteins with exposed extracellular domains for
two reasons: (i) a large number of disease related genes are mem-
brane proteins and (ii) the accessibility of membrane proteins for
drugs [9,10]. Disease-relevant and potentially druggable quantita-
tive changes in cell surface protein abundance levels of adipocytes
contributing to the various currently known malfunctions of adipo-
cytes in obesity have not been studied in detail.
Here, we used the recently developed Cell Surface Capture (CSC)
technology to establish surfaceome maps of primary adipocytes from
mouse models of obesity [11,12]. The CSC technology allows for the se-
lective, location-speciﬁc labeling of cell surface glycoproteins and their
subsequent mass-spectrometric identiﬁcation. By using the CSC tech-
nologywewere able tomeasure the relative abundance levels of several
hundred cell surface glycoproteins of primary adipocytes in lean and
obese mouse models. Relative quantitative analysis of the generated
surfaceome maps revealed obesity-induced changes of the abundance
levels of selected proteins. Through RNAi-mediated gene silencing we
could show that some of these deregulated cell surface glycoproteins
are functionally important since they were able to increase or decrease
adiponectin levels as well as regulate β-adrenergic mediated lipolysis.
2. Material and methods
2.1. Adipose tissue and mature adipocyte isolation from animal models
C57Bl/6J and ob/ob mice were kept on a 12-h/12-h light/dark cycle
with free access to food and water in a pathogen-free animal facility.
Groups of C57Bl/6J mice were fed a high-fat diet (Provimi Kliba AG)
containing 60% fat for 8 weeks. Serum adiponectin levels were mea-
sured with mouse Adiponectin ELISA Kit (Abnova) and fatty acids in
the serum were measured with the NEFA-HR kit (Wako Diagnostics).
At an age of 12–14 weeks, animals were fasted (12 h) and adipose tis-
sue was dissected. For lipolysis assays, the adipose tissue was cut into
small pads, incubated in Krebs Ringer Buffer and stimulated with
6 μM Isoproterenol or 100 nM Insulin. Released free fatty acids were
measured in supernatants with the NEFA-HR kit (Wako Diagnostics).
For Cell Surface Capture and qPCR the dissected adipose tissue was
digested for 1 h at 37 °C with Collagenase type II (Sigma-Aldrich) in
Krebs Ringer Buffer. After dissociation of the tissue, mature adipo-
cytes were separated from the stromal–vascular (SVF) fraction by
centrifugation at 200 ×g for 10 min at room temperature. Pelleted
SVF was ﬁltered through a 40 μm net and erythrocytes were lysed.
2.2. Real-time PCR
mRNA was isolated from adipose tissue, mature adipocytes as well
as the SVF and transcribed into cDNA with the Multi-MACS cDNA kit
(Miltenyi). mRNA expression was measured by real-time PCR using
SybrGreen (Invitrogen) according to the manufacturer's protocol.
mRNA expression levels were normalized to 36B4.The primer sets
used were speciﬁc for mouse 36B4 (forward 5′-GCCGTGATGCCCAGG
GAAGA-3′ and reverse 5′-CATCTGCTTGGAGCCCACGTT-3′), mouse aP2
(forward 5′-ATGAAATCACCGCAGACGACAG-3′ and reverse 5′-GCCTTT
CATAACACATTCCACCAC-3′), mouse CD68 (forward 5′-CACTTCGGGCC
ATGTTTCTCTT-3′ and reverse 5′-AGGGGCTGGTAGGTTGATTGT-3′),
mouse Pref-1 (forward 5′-CCCTGCGTGATCAATGGTTCTCC-3′ and re-
verse 5′-GCTGTTGGTTGCGGCTACGAT-3′), Adam10 (forward 5′-GGGAAGAAATGCAAGCTGAA -3′ and reverse 5′-CTGTACAGCAGGGTCCTTG
AC-3′) and CD38 (forward 5′-AAGATGTTCACCCTGGAGGA-3′ and re-
verse 5′-CTCCAATGTGGGCAAGAGGAC-3′).
2.3. Cell surface labeling, protein digestion and N-glycopeptide enrichment
Isolated adipocytes were transferred to a fresh tube and washed
with 10 mL labeling buffer (1×PBS pH 6.5). Cell surface labeling pro-
cedure as described previously [13] was adapted for primary adipo-
cytes. Primary adipocytes were incubated in labeling buffer in
perﬂuoroalkoxy coated tubes (Savillex) containing 1.6 mM sodium
periodate (Piercenet) for 10 min in the dark on a gentle rotator. Adipo-
cytes were washed and transferred into labeling buffer containing
5 mMbiocytin hydrazide (Biotium) and incubated for 1 h at room tem-
perature. Labeled cells were transferred to 1 mL lysis buffer (10 mM
Tris pH 7.5, 0.5 MMgCl2) and disruptedwith a VialTweeter (Hielscher).
Protein lysates were centrifuged at 2500 ×g to remove cell debris at
4 °C. Supernatant was transferred to Beckmann Ultra Clear centrifuge
tubes and mixed in a 1:1 ratio with membrane preparation buffer
(280 mM sucrose, 50 mM MES pH6, 450 mM NaCl and 10 mM
MgCl2), followed by ultracentrifugation for 90 min at 200,000 ×g at
4 °C. Membrane pellet was resolved in 500 μL digestion buffer
(100 mM Ammonium Bicarbonate and 0.1% Rapigest (Waters)). Prior
to digestion, proteins were reduced with 5 mM tris(2-carboxyethyl)
phosphine and alkylated with 10 mM Iodacetamide. Membrane pro-
teins were digested with Trypsin (Promega) for 12 h at 37 °C on an
overhead rotator at an enzyme protein ratio of 1:100. After digestion
biotin-labeled glycopeptides were incubated with strepdavidin beads
(Pierce). After extensive washing of the beads, N-glycosylated peptides
were released using the enzyme PNGaseF (New England Biolabs),
which cleaves between the proximal N-acetylglucosamine and the as-
paragine of glycopeptides. Enriched peptides were cleaned with C18
spin columns and dried in a Speed-vac.
2.4. Mass spectrometric analysis and data analysis
Samples were analyzed on a hybrid linear ion trap LTQ-FT (Thermo
Scientiﬁc, Bremen Germany) equipped with a nanoelectrospray ion
source (Thermo Scientiﬁc, Bremen Germany) coupled to a Tempo
1D-plus nanoLC system (Applied Biosystems/MDS Sciex, Foster City,
CA). Peptides were separated on a RP-HPLC column (75 μm × 10 cm)
packed in-house with C18 resin (Magic C18 AQ 3 μm; Michrom
BioResources, Auburn Canada). Peptides were eluted using a linear gra-
dient from 98% solvent A (98%water, 0.15% formic acid and 2% acetoni-
trile) and 2% solvent B (2% water, 0.15% formic acid and 98%
acetonitrile) to 30% solvent B over 60 min at a ﬂow rate of 0.3 μL/min.
Each survey scan acquired in the ICR cell at 100,000 FWHM was
followed by MS2 scans of the three most intense precursor ions in the
linear ion trap with enabled dynamic exclusion for 30 s. Charge state
screening was employed to select for ions with at least two charges
and rejecting ions with undetermined charge states. The normalized
collision energy was set to 32% and one microscan was acquired for
each spectrum. Raw data were converted to centroid and proﬁle
mzXML format using ReAdw [14] and spectra were matched against
the mouse IPI database version 3.26 using the Sequest algorithm [15].
Data were post processed using the TransProteomic Pipeline TPP21
v4.0 JETSTREAM rev 2 [16] including PeptideProphet [17] and
ProteinProphet [18]. For the identiﬁed proteins possessing at least one
peptide containing a deamidated asparagine, transmembrane domains
were assigned with the TMHMM algorithm and protein classes were
assigned with the Panther Classiﬁcation system [19,20].
For label-free MS1-based quantiﬁcation the SuperHirn software
[21] was used. Only peptides with a peptide probability higher than
0.9 and containing a deamidated asparagine residue were considered
for quantiﬁcation. Peptide intensities belonging to the same protein
were summed up.
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Fig. 1. Speciﬁcity of the applied enrichment strategy for plasma membrane proteins of adipocytes. (A) Relative mRNA levels of adipose tissue, isolated mature adipocytes and the
stromal–vascular fraction (SVF) of C57Bl/N6 mice for aP2, CD68 and Pref-1 normalized to 36B4 (**p ≤ 0.001).(B) The occurrence of transmembrane (TM) domains predicted by
TMHMM [20] for the identiﬁed proteins on the primary mouse adipocytes and the entire mouse IPI database. (C) Distribution of assigned protein classes by the Panther classiﬁca-
tion system [19] for the identiﬁed proteins on primary mouse adipocytes and for the entire mouse IPI database. (D) Enrichment of Panther protein classes for the experimental cell
surface dataset from the adipocytes compared to the entire mouse IPI database (Fisher's exact test #p ≤ 0.0001).
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BLOCK-iT™ Pol II miR RNAi sequences for target genes (Table 2 sup-
plementary data) were designed and cloned into the pcDNA™6.2-GW/
EmGFP-miR expression vector (Invitrogen). Replication incompetent
adenoviruses expressing the 156miR RNAi sequenceswere constructed
using Gateway Cloning and the Vira Power Adenoviral expression sys-
tem according to the manufacturer's instructions. Brieﬂy, the LR site
ﬂanked cassettes containing the emGFP miR RNAi sequences were
transferred to the pDONR 221 by BP clonase (Invitrogen) reactions
and further transferred to the adenoviral Gateway vector pAd/CMV/
V5-DEST by LR clonase (Invitrogen) reactions. For adenovirus
production, PAC1 linearized plasmids were transfected in HEK293A
cells following the manufacturer's guidelines. Viruses were harvested
and crude virus stocks were prepared trough repeated freeze–thaw
cycles.Fig. 2. Label-free quantiﬁcation of adipocyte cell surface proteins by mass spectrometry. (A
ipocytes derived from ob/obmice (correlation coefﬁcient r calculated by the Pearson's correl
obese mouse models illustrated by volcano plots comparing adipocytes from the subcutaneo
obmice (black). (C) Obesity-induced changes of cell surface proteins of adipocytes derived fr
(blue) and C57Bl/N6 against ob/obmice (black). (D) Obesity-induced changes of cell surface
C57Bl/N6 on a high fat diet (blue) and C57Bl/N6 against ob/obmice (black). (E) Heat map il
cutaneous and visceral fat depot of ob/ob mice and C57Bl/N6 mice fed a high fat diet. Heat m
subcutaneous fat depot or (G) the visceral fat depot. Abbreviations: subcutaneous (sc), visc2.6. Cell culture, adipogenic differentiation and adenoviral knockdown
HEK293A and 3T3-L1 preadipocytes were cultured in high-glucose
Dulbecco's modiﬁed Eagle's medium (Invitrogen) supplemented
with 10% fetal bovine serum and 1% penicillin/streptomycin. For
adipocyte differentiation 96-well plates were coated with collagen
and postconﬂuent 3T3-L1 pre-adipocytes were treated with induc-
tion cocktail (1 μg/mL insulin, 1 μM dexamethasone, 115 μg/mL
isobutyl-methylxanthine and 1 μM rosiglitazone). 48 h post induc-
tion, 3T3-L1 cells were transduced with crude adenovirus stocks.
Transduction efﬁciency was veriﬁed by GFP expression. Free fatty
acid and adiponectin measurements were performed in fully differenti-
ated 3T3-L1 cells 9 days after induction of adipogenesis. For free fatty
acid measurements cells were left unstimulated or stimulated with
6 μM Isoproterenol with or without 20 nM Insulin (in Krebs Ringer
buffer containing fatty acid free bovine serum albumin).) Scatter plot for the biological triplicates of the cell surface protein abundances of ad-
ation). (B) Adipose tissue depot speciﬁc differences of measured cell surface proteins of
us depot against the visceral depot from C57Bl/N6 mice fed a high fat diet (blue) and ob/
om the subcutaneous fat depot comparing C57Bl/N6 against C57Bl/N6 on a high fat diet
proteins of adipocytes derived from the visceral fat depot comparing C57Bl/N6 against
lustrating depot-speciﬁc differences of cell surface proteins observed between the sub-
ap illustrating obesity induced differences of cell surface proteins observed in the (F)
eral (vis), diet induced obesity (DIO).
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of differentiated 3T3L1 cells
For adiponectin measurements, cell culture supernatants were
diluted 1:50 and analyzed with a mouse Adiponectin Kit (Panomics)
on amicro-bead assay system (Luminex). Free fatty acids in superna-
tants were measured with the NEFA-HR kit (Wako Diagnostics).
2.8. Statistical analysis
Two tailed Student's t-test or the Fisher's exact test was used to
determine signiﬁcance of differences between two groups.
3. Results
3.1. Surfaceome characterization of primary mouse adipocytes
To identify location-speciﬁc obesity-induced changes in plasma
membrane glycoprotein levels contributing to the malfunctions of
adipocytes in obesity, we analyzed plasma membrane proteins of
primary adipocytes by using CSC technology and compared the rela-
tive protein abundance levels between obese and lean mice. For CSC
analyses we dissected subcutaneous and visceral adipose tissue from
leptin deﬁcient (ob/ob) mice [22] and wild-type mice (C57Bl/N6)
that had been kept on a high fat diet for 8–10 weeks as a model for
diet induced obesity (DIO). As a lean control, C57Bl/N6 mice were
kept on a chow diet. Prior to cell surface labeling of live cells, mature
adipocytes were separated from the stromal–vascular fraction of the
adipose tissue. The purity of the adipocyte fraction in respect to macro-
phage contamination was accessed by qPCR using CD68 as a marker for
macrophages. As shown in Fig. 1A the relative mRNA levels of CD68 are
depleted in the isolated adipocytes compared to the stromal–vascular
fraction (SVF) as well as to the whole adipose tissue. Conversely, the
mature adipocytemarker aP2washighly enriched in the adipocyte frac-
tion compared to the SVF of the adipose tissue. Isolated mature adipo-
cytes were gently oxidized to introduce aldehydes as new chemical
moieties in the carbohydrates of cell surface glycoproteins. In a second
step, these newly generated aldehydes are captured with biocytin hy-
drazide, leading to a carbohydrate-directed biotinylation of cell surface
glycoproteins on live cells which enables enrichment of glycopeptides
and their subsequent mass-spectrometric identiﬁcation. Critical for
the success of the CSC labeling, and to avoid unspeciﬁc tagging of intra-
cellular proteins, is the viability and integrity of the cells. Therefore, the
CSC protocol was optimized and adapted for primary adipocytes which
are typically fragile and tend to stick to plastic surfaces. Performing the
labeling procedure in Teﬂon (perﬂuoroalkoxy)-coated tubes proved to
be important. Teﬂon prevented the adherence of the cells to the tube
walls which reduced the disruption and increased the viability of
primary adipocytes during the labeling procedure. In a total of 17
high-resolution LC–MS/MS runs, we were able to identify 431 proteins
and thereof 361 glycoproteins (84%) (Table 1 supplementary data). To
quantify the speciﬁcity of the cell surface capturing approach for plasma
membrane proteins we analyzed the detected proteins with the trans-
membrane prediction algorithm TMHMM [20]. This analysis showed
that over 65% of the proteins possess at least one transmembrane do-
main which represents almost a 3-fold enrichment compared to the
whole IPI database (Fig. 1B). Further classiﬁcation of the identiﬁed adi-
pocyte surfaceomemembers using the Panther classiﬁcation system re-
vealed that the receptor, transporter and cell adhesion classes are
predominant in the dataset (Fig. 1C) [19]. A comparison to the complete
IPI database showed that the classes of cell adhesion molecules, extra-
cellular matrix proteins and receptors are enriched whereas the nucleic
acid-binding proteins and transcription factors are completely depleted
from the plasma membrane protein enriched samples (Fig. 1D). This in
silico analysis of the measured cell surface proteins of primaryadipocytes underscores the speciﬁcity of the used enrichment strategy
for cell surface proteins.
3.2. Label-free relative quantiﬁcation of plasma membrane proteins of
primary mouse adipocytes in obesity
To quantify changes either between the different fat depots (sub-
cutaneous and visceral) or between the obese and lean mouse models
we used label-free quantiﬁcation based on MS1 precursor signal in-
tensities. Data were normalized and relative protein abundances
were obtained based on the extracted peptide intensities (Fig. 2A).
First, we investigated fat depot speciﬁc differences of cell surface
proteins of adipocytes obtained from two obese mouse models. In this
analysis we compared the measured plasma membrane protein levels
of subcutaneous versus visceral adipocytes of the diet induced mouse
models (DIO) and the genetic model (ob/ob). In order to ﬁnd the most
meaningful changes the p-value was plotted against the log ratio
(Fig. 2B). In both models we were able to measure the consistent
up-regulation of L1 cell adhesion molecule (L1cam), laminin alpha 4
(Lama4), membrane metallo-endopeptidase (Mme) and integrin
alpha 3 (Itga3) in the subcutaneous tissue compared to the visceral ad-
ipose tissue (Fig. 2E). On the other handwe could measure a consistent
elevation of 14 molecules including angiotensin converting enzyme
(Ace), alanyl (membrane) aminopeptidase N (Anpep), scavenger re-
ceptor class B member 1 (Scarb1), mannose-6-phosphate receptor
(M6pr) and protein tyrosine phosphatase receptor type J (Ptprj) in
the visceral fat depot compared to the subcutaneous depot. This panel
of proteins can be classiﬁed as fat depot speciﬁc proteins that show an
alteration in protein abundance levels in obesity.
Next, we aimed to investigate the differences between obese and
lean mice. For the comparison of the obese mouse models to the lean
control in adipocytes derived from subcutaneous depot we mea-
sured the down-regulation of macrophage galactose N-acetyl-
galactosamine speciﬁc lectin 2 (Mgl2) and the up-regulation of a
large panel of proteins including natriuretic peptide receptor C
(Npr3), disintegrin and metalloproteinase domain 10 (Adam10),
oncostatin M receptor (Osmr), ﬁbroblast activation protein (Fap),
N-acetylated-alpha-linked acidic dipeptidase II (Naalad2), Scarb1,
low density lipoprotein receptor-related protein 1 (Lrp1) and ecto-5′-
nucleotidase (Nt5e) (Fig. 2C and F). For the visceral depot we could
measure the down-regulation of Mgl2 as well and the up-regulation
of several surface molecules including Osmr, Lrp1, Scarb1, Npr3 and
Naalad2 (Fig. 2D and G).
Taken together we could detect depot-speciﬁc differences as well as
obesity-induced changes (Fig. 2E, F and G) in adipose tissue. Based on
these results, candidate proteins were further studied with regard to
their functional role on adipocyte metabolism in obesity.
3.3. Cell surface proteins of adipocytes alter adiponectin secretion
Hypoadiponectinemia is considered a risk factor for themetabolic
syndrome [23]. Adiponectin is an insulin sensitizing factor that can
reverse insulin resistance in peripheral tissues. Accordingly, over-
expression of adiponectin has been shown to prevent weight gain
[24]. We measured adiponectin levels with an ELISA in ob/ob mice
(ob/ob) and C57Bl/N6 mice. As expected serum adiponectin levels of
ob/ob mice were reduced by more than a factor 2 (p b 0.001, Fig. 3A)
in both fasted and fed state compared to lean C57Bl/N6. In a next ap-
proach, we tested the previously identiﬁed plasmamembrane proteins
with altered protein abundance in obesity (n = 39) for their po-
tential inﬂuence on adiponectin levels. For the functional charac-
terization of these proteins we decided to use gene silencing by
adenovirus-delivered RNAi. We designed 4 independent expression
vectors containing RNAi constructswith cocistronical emGFP expression
for each protein of interest. 3T3-L1 cells were transduced with the ade-
noviral library two days after induction of adipogenic differentiation to
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Fig. 3. Identiﬁcation of plasma membrane glycoproteins inﬂuencing adiponectin levels.
(A) Serum adiponectin levels of ob/ob mice are decreased compared to C57Bl/N6 mice
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entiated 3T3-L1 cells after RNAi-mediated gene silencing (dashed line p-value = 0.05)
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The degree of adipogenesis was conﬁrmed by lipid droplet stainings
and found to be not affected by any of the constructs tested (data not
shown). In entirely differentiated adipocytes, 9 days post induction
adiponectin levels were measured in quadruplicates in the supernatant.
Proteins were considered to inﬂuence adiponectin levels when at least
two independent constructs of the same protein changed adiponectin
levels with statistical signiﬁcance (p b 0.05, Fig. 3B and C). Gene silenc-
ing of Fap, Scarb1 and Lama4 increased adiponectin levels. Decreased
levels of Fap belonging to the family of serine proteases showed the
strongest increase in adiponectin levels. On the other hand knockdown
of L1cam and Mme decreased the measured adiponectin levels.
Taken together we could show that ﬁve of the proteins that are
deregulated on the adipocyte surface during obesity contribute to
adiponectin secretion from these cells.
3.4. Cell surface proteins effecting lipolytic activity of adipocytes
Increased free fatty acids in the serum during feeding due to insu-
lin resistance in the adipose tissue contribute to the deposition of
lipids in other organs. This is supported by the fact that ob/ob mice
are not able to reduce free fatty acid levels after feeding (Fig. 4A).
In addition free fatty acid levels in the fed state were twice as high
in the ob/ob mice compared to C57Bl/N6 mice. Furthermore, the re-
sponse to β-adrenergic stimulation in the subcutaneous as well as
the visceral fat depot is blunted in ob/ob mice compared to C57Bl/
N6 mice as previously reported by Collins et al. (Fig. 4B) [25]. In
order to test, whether the differentially regulated plasma membrane
proteins inﬂuence the lipolytic activity of adipocytes we used the
above mentioned adenoviral RNAi library to measure free fatty acid
release in differentiated 3T3-L1 cells. After adenovirus-mediated
gene silencing we measured released free fatty acids in the basal
state (no stimulation), after β-adrenergic stimulation (isoprotere-
nol) and after insulin and β-adrenergic stimulation in fully differen-
tiated 3T3-L1 cells (9 days postinduction).
The reproducibility of the RNAi screen is conﬁrmed by the high
correlation coefﬁcient of 0.84 between biological replicates (Fig. 4C).
We set the cut-off for increased or decreased free fatty acid release
using the average of the RNAi controls ± 2 times the standard devia-
tion (Fig. 4D and 4F). Only proteins which showed changed lipolytic
activity with at least two independent constructs were considered
to modify adipocyte function.
Without any stimulation (basal lipolysis) we did not observe al-
tered release of free fatty acids (data not shown) with at least two in-
dependent constructs. We conclude that in our used system the
targeted proteins did not inﬂuence the unstimulated lipolytic activity
of differentiated 3T3-L1 cells.
In contrast to the results of the unstimulated lipolytic activity we
identiﬁed several targets which are responsible for changing free
fatty acid release after isoproterenol stimulation of adipocytes. The si-
lencing of Cyclic ADP-ribose hydrolase (Cd38), Anpep, Ace, Adam10,
Itga3, M6pr, Osmr, Lrp1, Nt5e, Ptprj and Naalad2 led to an increase
of the β-adrenergic stimulated lipolysis with at least 2 independent
constructs as measured by an increase in released free fatty acids in
the supernatant (Fig. 4D and E). All these cell surface proteins can
be classiﬁed as suppressors of β-adrenergic lipolysis. The most prom-
ising suppressor of β-adrenergic lipolysis is Cd38 which increased the
β-adrenergic dependent lipolysis after silencing with all 4 constructs
(Fig. 4E). Anpep and Ace enhanced lipolytic activity with 3 indepen-
dent constructs. On the other hand embigin (Emb) decreased the
β-adrenergic stimulated lipolysis with two independent constructs
and can thus be classiﬁed as an enhancer of β-adrenergic lipolysis
(Table 1).
To determine the inhibitory effect of insulin, free fatty acid release
was measured under the simultaneous treatment with insulin and
isoproterenol of differentiated 3T3-L1 cells. To elucidate the effectof insulin, relative FFAs levels between the combined stimulus and
isoproterenol alone were calculated (Fig. 4F). Using this paradigm,
we could show an increased sensitivity to insulin after gene silencing
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structs (Fig. 4G). Thus, these proteins can be classiﬁed as suppressors
of the inhibitory effect of insulin on lipolysis. By random testing
of the RNAi constructs belonging to genes affecting adipocytefunctions, we measured signiﬁcant gene silencing by qPCR for all
four constructs of CD38 and two constructs of Adam10 (Fig. 4H, I)
which is concurrent with the effects observed in the lipolysis
screen.
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So far the cell surface proteomeof primarymouse adipocytes has not
been analyzed bymass spectrometrywhich ismainly due to challenging
properties of primary adipocytes and membrane proteins at the same
time. In recent years, proteomic analysis of mature adipocytes and the
adipose tissue has focused on the secretome in order to identify new
adipokines [26–28]. The proteome of the 3T3-L1 cell line including its
surfaceome has been characterized in the context of adipogenesis but
cannot reﬂect the dysfunctional primary adipocytes found in obesity
[29,30]. Neverthelesswe compared our cell surface dataset from the pri-
mary mouse adipocytes with the surfaceome of the 3T3-L1 cells from
Prior et al. [30] and we found an overlap between the two datasets of
31%. The cause for the relative low coverage could be either the different
techniques used for plasma membrane enrichment or the differences
between the primary mouse adipocytes and the 3T3-L1 cell line. Fur-
thermore, the small overlap underscores the need to study the prote-
ome of primary adipocytes in general. Blüher et al. characterized
protein abundance levels of primary mouse adipocytes of FIRKO (fat
speciﬁc insulin receptor knockout) mice in the context of adipocyte
size and insulin resistance using different fractionation methods
followed by SDS-polyacrylamide gels [31]. Our label-free mass
spectrometry-based approach combined with the CSC technology en-
abled us to selectively enrich for plasma membrane glycoproteins and
to remove adipocyte lipids which otherwise complicate mass spectro-
metric analyses. The purity of the adipocyte fractions we validated by
qPCR using marker genes for adipocytes, macrophages and adipocyte
precursors. The mRNA levels of the macrophage marker CD68 and the
preadipocytemarker Pref-1were enriched in the stromal–vascular frac-
tion compared to the isolated mature adipocytes, whereas aP2 was
enriched in the mature adipocytes proving the decrease of these cell
types in the mature adipocyte fraction. The chemoproteomic CSC strat-
egy allowed us to quantify plasmamembrane glycoproteins on the sur-
face of primary adipocytes of obese and lean mice. We identiﬁed depot
speciﬁc changes of cell surface proteins of adipocytes of obese mice as
well as differences in cell surface protein expression patterns between
adipocytes of obese mice compared to lean mice. The observed
surfaceome changes implicate a heterogeneity of adipocyte subpopula-
tions which is also reﬂected by their different functional capacities.
In order to link the observed quantitative surfaceome changes to
adipocyte malfunction in obesity we examined the effects of candi-
date protein depletion on adiponectin secretion and the lipolytic ac-
tivity of adipocytes using a targeted screening approach. The gene
silencing efﬁciency of the used RNAi constructs were assessed by ran-
dom testing. To ensure a low number of false positive hits caused by
unwanted off-target effects, we required for both functional screens
at least two independent constructs of the same protein to alter adi-
pocyte function. Independent constructs silence the same on-target
gene while the off-target effect is supposed to be unique and thereby
the occurrence of unwanted off-targets is reduced. Adiponectin se-
cretion by the adipose tissue is decreased in obesity and adiponectin
is a known insulin sensitizer that is able to reverse insulin resistance
in the muscle of obese mice [32–34]. Silencing of Fap and Scarb1 in-
creased secreted adiponectin levels, whereas silencing of Mme and
L1cam decreased the amount of secreted adiponectin. The used
screening approach does not reveal the direct inﬂuence of these sur-
face proteins on adiponectin secretion, the observed effects can also
be mediated by transcriptional changes. Scarb1 and Fap were both
up-regulated in the used obese mouse models and the silencing or
the inhibition of these molecules could be an interesting approach
to increase adiponectin levels in order to improve or prevent the
metabolic complications in obesity.
In a recent study analyzing lipid turnover in the human adipose tis-
sue by 14C measurements, Arner et al. found that protein kinase A de-
pendent lipolysis determines lipid turnover [35]. The authors propose
to target triglyceride turnover for the prevention and treatment
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the reported catecholamine resistance found in obese patients
[6,7,36,37]. Therefore, increasing or restoring the sensitivity to
β-adrenergic lipolysis could also increase the lipid turnover in the
adipocyte and prevent the hypertrophic phenotype of adipocytes
and the resulting metabolic complications. We could show here
that the lipolytic activity of adipocytes is not only dependent on
the ratio of α-adrenergic and β-adrenergic receptors, but also the
abundance of other cell surface proteins. In our experiments silenc-
ing of these cell surface proteins improved the β-adrenergic sensitiv-
ity of adipocytes. Furthermore Cd38, Adam10, Osmr, Lrp1, Nt5e,
Ptprj and Naalad2were up-regulated in the obesemousemodels. Ac-
cordingly, silencing or inhibition of these cell surface proteins can be
an interesting approach to increase or restore the β-adrenergic depen-
dent lipolysis in obesity leading to an increased triglyceride turnover.
Beside β-adrenergic receptor agonists, natriuretic peptides are known
as potent stimulators of lipolysis. Natriuretic peptides and Npr3 are
known to be involved in lipolysis by a β-adrenergic independent path-
way ([38,39]). We could demonstrate the up-regulation of Npr3 in the
obese mouse models, however the here used β-adrenergic dependent
lipolysis assay is not suitable to afﬁrm the implication of Npr3 into
lipolysis.
In summary, we could show that obesity-induced changes of cell
surface proteins inﬂuence the functional capacity of adipocytes and
contribute to adipocyte function in vitro. The identiﬁed cell surface pro-
teins capable to improve hypoadiponectinema and β-adrenergic lipoly-
sis (catecholamine resistance) are potential new targets to antagonize
adipocyte malfunction in obesity and to prevent from the metabolic
consequences of lipid-overloaded adipocytes.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbalip.2013.04.001.
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